國軒高科(002074.SZ)籌劃重大事項或導致實控權變更 明起停牌
格隆匯5月19日丨國軒高科(002074.SZ)公佈,公司董事會於近日收到公司實際控制人李縝及其一致行動人珠海國軒貿易有限責任公司、李晨的通知,其正在籌劃股權轉讓事宜,擬向戰略投資者轉讓其持有的部分公司股權並涉及其他表決權安排。前述事項可能導致公司第一大股東及實際控制權的變更。本次交易對手方屬於製造業,該事項仍然涉及有關部門的事前審批。
公司股票和可轉換公司債券自2020年5月20日(星期三)上午開市起停牌,本次停牌預計不超過5個交易日。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.